Achieve electronic supervision at the end of the "Twelfth Five-Year Plan"

On October 21st, the first session of the China-ASEAN Forum on Drug Safety and Drug Administration Authority was held in Nanning, Guangxi. Shao Mingli, vice minister of the Ministry of Health and director of the State Food and Drug Administration, said at the meeting that China will further strengthen the regulatory capacity of the pharmaceuticals market. By 2015, it will implement electronic supervision of all listed drugs to ensure the controllability of the quality of pharmaceutical production and circulation. Traceability.

According to reports, China has now completed the electronic supervision of high-risk varieties such as narcotic drugs, psychoactive drugs, blood products, vaccines and Chinese medicine injections. On April 1st this year, on the basis of realizing the electronic supervision of participating in bidding for essential drug varieties, the State Food and Drug Administration will continue to expand the scope of electronic supervision. By the end of February 2012, it will realize the electronic supervision of all types of essential drugs and go to the "Twelfth Five-year Plan". At the end, electronic surveillance of all drugs was implemented.

Shao Mingli said that China will also increase investment in improving drug regulatory technology capabilities and strengthen the construction of inspection and detection, risk early warning and other systems, including accelerating the application of rapid drug testing technologies, strengthening the monitoring of adverse drug reactions, and improving emergency response capabilities, etc. . It is reported that the two-day forum featured the theme of "strengthening communication, safeguarding safety, and seeking common development -- pharmaceutical safety cooperation under the development of China-ASEAN Free Trade Area".